Cell-Easy is a specialised contract development and manufacturing organisation (CDMO) focused on providing expert services in the field of cell therapy. They support biopharma companies with cutting-edge cell culture expertise, offering tailored process development, GMP manufacturing, and analytical services for immune cells and stem cells.

With a deep commitment to advancing immuno-oncology and regenerative medicine, Cell-Easy delivers comprehensive solutions for the development of cell-based therapies. The company leverages over 300 years of combined experience in cell culture to ensure high-quality results throughout the entire lifecycle, from preclinical to clinical-stage product development.

Key Products and Services

• Cell-based therapy development (immune cells, adult stem cells)
• GMP manufacturing for cell-based therapies
• Process development and scale-up
• Analytical testing and potency assay development
• Cell banking and ATMP manufacturing
• Regulatory support tailored for cell products
• Project management and risk mitigation services

Cell-Easy aims to transform laboratory innovations into viable clinical therapies by offering customised, science-driven services. Their focus on meeting timelines, budgets, and regulatory compliance ensures successful outcomes for their clients.